1.
Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.
2.
Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology
3.
4.
5.
6.